Huang J D, Oie S
J Pharmacol Exp Ther. 1982 Nov;223(2):469-71.
This study was undertaken to determine whether pharmacologic response to disopyramide is related to unbound or to total plasma concentration. Pharmacologic response, measured as changes in QRS duration of the EKG, was determined in rabbits at various steady-state concentrations of disopyramide under normal and altered plasma protein binding conditions. Plasma protein binding was increased by injection of 40 mg/kg of human glycoprotein fraction VI. The concentration-response curve for total concentration was displaced toward higher concentrations after increasing the plasma protein binding of disopyramide. The concentration-response curves obtained for unbound drug with and without the increased binding were superimposable. The displacement of the concentration-response curve for total drug was identical to the increase in concentration of the bound drug in plasma. These results demonstrate that the unbound concentrations of disopyramide in plasma are a better measure of the pharmacologic response than is the total plasma concentration.
本研究旨在确定丙吡胺的药理反应与未结合血浆浓度还是总血浆浓度相关。在正常和改变血浆蛋白结合条件下,于不同稳态浓度的丙吡胺时测定家兔的药理反应,以心电图QRS波时限变化来衡量。通过注射40mg/kg人糖蛋白组分VI增加血浆蛋白结合。增加丙吡胺的血浆蛋白结合后,总浓度的浓度-反应曲线向更高浓度偏移。结合增加和未增加时未结合药物获得的浓度-反应曲线可重叠。总药物浓度-反应曲线的偏移与血浆中结合药物浓度的增加相同。这些结果表明,血浆中丙吡胺的未结合浓度比总血浆浓度更能衡量药理反应。